Zobrazeno 1 - 10
of 10
pro vyhledávání: '"M N Yadrikhinskaya"'
Publikováno v:
Сахарный диабет, Vol 14, Iss 1, Pp 53-60 (2011)
Congestive heart failure, diabetes mellitus, and ciliary arrhythmia are three epidemic cardiovascular conditions threatening the mankind in the XXIcentury. Ciliary arrhythmia is the commonest disturbance of cardiac rhythm characterized by inability o
Externí odkaz:
https://doaj.org/article/b54c539d4afb43888fbfc0ef087dd0d9
Autor:
Andrey Alexeevich Aleksandrov, Irina Ziyatovna Bondarenko, Svetlana Semenovna Kukharenko, M N Yadrikhinskaya, Irina Ivanovna Mart'yanova, Yu A Solyanik, E N Drozdova, Alexander Yur'evich Mayorov
Publikováno v:
Сахарный диабет, Vol 8, Iss 3, Pp 34-38 (2005)
Смертность от ИБС в популяции лиц, страдающих сахарным диабетом 2 типа (СД 2), продолжает расти во всем мире, несмотря на постоянное увелич
Externí odkaz:
https://doaj.org/article/566af02e9198402fb3f00653ae9c73a4
Autor:
Andrey Alexeevich Aleksandrov, Irina Ziyatovna Bondarenko, Svetlana Semenovna Kukharenko, M N Yadrikhinskaya, V G Vilkov, F D Akhmatova, V K Aleksandrova, N V Artamonova, O E Solov'eva, Ivan Ivanovich Dedov
Publikováno v:
Сахарный диабет, Vol 5, Iss 4, Pp 18-22 (2002)
Последствия применения препаратов сульфонилмочевины свидетельствуют о том, что с точки зрения сердечно-сосудистых эффектов сульфанил
Externí odkaz:
https://doaj.org/article/427eb696f7414cce9763d133012fec6e
Autor:
Svetlana Semenovna Kukharenko, Marina Vladimirovna Shestakova, M N Yadrikhinskaya, Aleksandra L. Kudryashova, E N Drozdova, Ivan Ivanovich Dedov, Olga Alexandrovna Shatskaya
Publikováno v:
Problems of Endocrinology. 62:10-19
Aim — to compare the features of diastolic dysfunction (DD) with preserved left ventricular (LV) ejection fraction (EF) in patients with diabetes mellitus type 2 (DM2) with arterial hypertension (AH) and in patients with essential hypertension (EH)
Autor:
Svetlana Semenovna Kukharenko, M N Yadrikhinskaya, Andrey Alexeevich Aleksandrov, Olga Alexandrovna Shatskaya
Publikováno v:
Сахарный диабет, Vol 15, Iss 2, Pp 70-76 (2012)
It is now well established that clinical use of statins for primary and secondary prevention of cardiovascular complications in patientswith diabetes mellitus (DM) increases life expectancy. At the same time, meta-analysis of major randomized trials
Publikováno v:
Сахарный диабет, Vol 14, Iss 1, Pp 53-60 (2011)
Congestive heart failure, diabetes mellitus, and ciliary arrhythmia are three epidemic cardiovascular conditions threatening the mankind in the XXIcentury. Ciliary arrhythmia is the commonest disturbance of cardiac rhythm characterized by inability o
Publikováno v:
Сахарный диабет, Vol 13, Iss 4, Pp 30-37 (2010)
The modern algorithm of hypoglycemic therapy for patients with type 2 diabetes mellitus (DM2) has been designed to effectively reach the ?target?blood glucose and HbA1c levels associated with the lowest mortality rate.The most popular scheme is combi
Autor:
I Z Bondarenko, O A Shatskaya, M N Yadrikhinskaya, S S Kukharenko, E N Drozdova, M V Shestakova
Publikováno v:
Ожирение и метаболизм, Vol 6, Iss 2, Pp 24-28 (2009)
Diabetes mellitus type 2 (DM2) - is an independent predictor of development of heart failure (HF). Spiroergometry - is a method for studying blood gas exchange parameters, commonly used for specification of HF. The purpose: 1. To study features of ga
Autor:
Yu A Solyanik, Alexander Yur'evich Mayorov, Svetlana Semenovna Kukharenko, M N Yadrikhinskaya, Andrey Alexeevich Aleksandrov, Irina Ivanovna Mart'yanova, E N Drozdova, Irina Z. Bondarenko
Publikováno v:
Сахарный диабет, Vol 8, Iss 3, Pp 34-38 (2005)
Смертность от ИБС в популяции лиц, страдающих сахарным диабетом 2 типа (СД 2), продолжает расти во всем мире, несмотря на постоянное увелич
Autor:
N V Artamonova, F D Akhmatova, Andrey Alexeevich Aleksandrov, O E Solov'eva, V K Aleksandrova, V G Vilkov, Irina Z. Bondarenko, M N Yadrikhinskaya, Ivan Ivanovich Dedov, Svetlana Semenovna Kukharenko
Publikováno v:
Сахарный диабет, Vol 5, Iss 4, Pp 18-22 (2002)
Последствия применения препаратов сульфонилмочевины свидетельствуют о том, что с точки зрения сердечно-сосудистых эффектов сульфанил